Target Name: MCTP2
NCBI ID: G55784
Review Report on MCTP2 Target / Biomarker Content of Review Report on MCTP2 Target / Biomarker
MCTP2
Other Name(s): multiple C2 and transmembrane domain containing 2 | MGC111402 | Multiple C2 and transmembrane domain containing 2, transcript variant 1 | MCTP2_HUMAN | Multiple C2 and transmembrane domain-containing protein 2 (isoform 1) | Multiple C2 and transmembrane domain-containing protein 2 | multiple C2 domains, transmembrane 2 | FLJ33303 | Multiple C2-domains with two transmembrane regions 2 | multiple C2-domains with two transmembrane regions 2 1 | FLJ11175 | MCTP2 variant 1

MCTP2: A Multiple C2 and Transmembrane Domain Containing 2 Protein

MCTP2, also known as multiple C2 and transmembrane domain containing 2, is a protein that is expressed in various tissues and cells throughout the body. It is a member of the superfamily of C2-type water channels, which are characterized by the presence of a transmembrane domain and multiple C2 domains. These channels are involved in a wide range of physiological processes, including ion and solute transport, and are expressed in many different tissues, including the brain, heart, and kidney.

One of the unique features of MCTP2 is its ability to form a transmembrane pore, which allows it to regulate the movement of ions and solutes through the cell membrane. This pore is formed by the interaction of the transmembrane domain with the cytoplasmic side of the channel, and is critical for the efficient transport of molecules across the membrane.

MCTP2 is also characterized by the presence of multiple C2 domains, which are involved in the regulation of channel function. These domains include an N-terminal transmembrane domain, a catalytic C2 domain, and a C3 domain that is located on the cytoplasmic side of the channel. The N-terminal transmembrane domain is involved in the regulation of channel stability and is thought to play a role in the regulation of ion and solute transport. The catalytic C2 domain is involved in the regulation of channel function and is thought to play a role in the catalytic mechanism of channel opening. The C3 domain is involved in the regulation of channel stability and is thought to play a role in the regulation of ion and solute transport.

MCTP2 is expressed in a wide range of tissues and cells throughout the body, including the brain, heart, and kidney. It is also highly expressed in the placenta, which is responsible for the supply of oxygen and nutrients to the developing fetus. MCTP2 is thought to be involved in the regulation of ion and solute transport in the placenta, including the transport of oxygen and nutrients across the cell membrane.

In addition to its role in ion and solute transport, MCTP2 is also involved in the regulation of cell signaling pathways. It is a component of several signaling pathways that are involved in the regulation of cell growth, differentiation, and survival. MCTP2 is also thought to be involved in the regulation of cell migration and the assembly of tissues.

Given its role in a wide range of physiological processes, MCTP2 is a potential drug target. Researchers are currently working to develop new therapies that can modulate the function of MCTP2 and its associated signaling pathways. These therapies are being tested in a variety of animal models, including mice, dogs, and humans.

In conclusion, MCTP2 is a protein that is expressed in various tissues and cells throughout the body. It is a member of the superfamily of C2-type water channels and is characterized by the presence of a transmembrane domain and multiple C2 domains. MCTP2 is involved in a wide range of physiological processes, including ion and solute transport, cell signaling pathways, and cell migration. Given its potential role in these processes, MCTP2 is an attractive target for drug development.

Protein Name: Multiple C2 And Transmembrane Domain Containing 2

Functions: Might play a role in the development of cardiac outflow tract

The "MCTP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MCTP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MCTS1 | MCTS2 | MCU | MCUB | MCUR1 | MDC1 | MDFI | MDFIC | MDGA1 | MDGA2 | MDH1 | MDH1B | MDH2 | MDK | MDM1 | MDM2 | MDM4 | MDN1 | MDS2 | ME1 | ME2 | ME3 | MEA1 | MEAF6 | MEAF6P1 | MEAK7 | Mechanoelectrical transducer (MET) channel | Mechanosensitive Ion Channel | MECOM | MECOM-AS1 | MeCP1 histone deacetylase (HDAC) complex | MECP2 | MECR | MED1 | MED10 | MED11 | MED12 | MED12L | MED13 | MED13L | MED14 | MED14P1 | MED15 | MED15P8 | MED16 | MED17 | MED18 | MED19 | MED20 | MED21 | MED22 | MED23 | MED24 | MED25 | MED26 | MED27 | MED28 | MED29 | MED30 | MED31 | MED4 | MED4-AS1 | MED6 | MED7 | MED8 | MED9 | MEDAG | Mediator Complex | Mediator of RNA Polymerase II Transcription | MEF2A | MEF2B | MEF2C | MEF2C-AS1 | MEF2C-AS2 | MEF2D | MEFV | MEG3 | MEG8 | MEG9 | MEGF10 | MEGF11 | MEGF6 | MEGF8 | MEGF9 | MEI1 | MEI4 | MEIG1 | MEIKIN | MEIOB | MEIOC | MEIOSIN | MEIS1 | MEIS1-AS2 | MEIS1-AS3 | MEIS2 | MEIS3 | MEIS3P1 | MEIS3P2 | Melanin | Melanin-concentrating hormone (MCH) receptor